Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity

Matthew T. Chang(Memorial Sloan Kettering Cancer Center), Saurabh Asthana(University of California, San Francisco), Sizhi Paul Gao(Memorial Sloan Kettering Cancer Center), Byron Lee(Memorial Sloan Kettering Cancer Center), Jocelyn Chapman(University of California, San Francisco), Cyriac Kandoth(Memorial Sloan Kettering Cancer Center), Jianjiong Gao(Memorial Sloan Kettering Cancer Center), Nicholas D. Socci(Memorial Sloan Kettering Cancer Center), David B. Solit(Memorial Sloan Kettering Cancer Center), Adam B. Olshen(University of California, San Francisco), Nikolaus Schultz(Memorial Sloan Kettering Cancer Center), Barry S. Taylor(Memorial Sloan Kettering Cancer Center)
Nature Biotechnology
November 30, 2015
10.1038/nbt.3391
Cited by 828Open Access
Full Text

Abstract

Related Papers

The control of the false discovery rate in multiple testing under dependency
Yoav Benjamini, Daniel Yekutieli|The Annals of Statistics|2001|10.8k
Cancer Genome Landscapes
Bert Vogelstein, Nickolas Papadopoulos, Victor E. Velculescu et al.|Science|2013|8k
Integrated genomic characterization of endometrial carcinoma
Douglas A. Levine|Nature|2013|5.8k
Mutational heterogeneity in cancer and the search for new cancer-associated genes
Michael S. Lawrence, Petar Stojanov, Paz Polak et al.|Nature|2013|5.7k
Mutational landscape and significance across 12 major cancer types
Cyriac Kandoth, Michael D. McLellan, Fabio Vandin et al.|Nature|2013|4.5k